Clinical trial

Study of Uridine Triphosphate (UTP) as an Aerosol Spray for Cystic Fibrosis

NCT00004705 · FDA Office of Orphan Products Development, U.S. Fed · Completed

Key facts

NCT number NCT00004705
Title Study of Uridine Triphosphate (UTP) as an Aerosol Spray for Cystic Fibrosis
Lead sponsor FDA Office of Orphan Products Development, U.S. Fed
Collaborators University of North Carolina
Status Completed
Study type Interventional
Conditions Cystic Fibrosis
Intervention type Drug
Interventions amiloride, uridine
Start date Sep 1, 1996
Completion Jan 1, 1999
First posted Feb 25, 2000
Last update posted Mar 25, 2015

At a glance

  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies